This metabolic profile is quite opposite to human obesity-associated NASH, which may explain the discrepancy observed in hepatic steatosis between the MCD-fed CXCL10−/− mice in the study by Zhang et al. vs. FFC-fed CXCL10−/− mice in the current study. The gene discussed is CXCL10; the disease is obesity disorder.